These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 82617)

  • 21. A comparison of the anti-anaphylactic activities of salbutamol and disodium cromoglycate in the rat, the rat mast cell and in human lung tissue.
    Butchers PR; Fullarton JR; Skidmore IF; Thompson LE; Vardey CJ; Wheeldon A
    Br J Pharmacol; 1979 Sep; 67(1):23-32. PubMed ID: 115530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potent inhibitory activity of HSR-6071, a new antiallergic agent, on passive cutaneous anaphylaxis (PCA).
    Makino E; Ohashi T; Takahashi H; Kato H; Ito Y; Nagai H; Koda A; Azuma H
    Jpn J Pharmacol; 1990 Jan; 52(1):87-94. PubMed ID: 1689783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 6,8-Di-t-butyl-4-oxo-4H-1-benzopyran-2-carboxylic acid: a chromone derivative with anti-allergic, anti-inflammatory and uricosuric activity.
    Augstein J; Cairns H; Chambers A; Burns JW; Radziwonik H
    J Pharm Pharmacol; 1976 Dec; 28(12):919-20. PubMed ID: 12270
    [No Abstract]   [Full Text] [Related]  

  • 24. The inhibition of histamine release by antiallergic drugs.
    Nagai H; Kelly K; Sehon AH
    Int Arch Allergy Appl Immunol; 1978; 56(4):307-15. PubMed ID: 75849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiallergy activity of substituted 11-oxo-11 H-pyrido[2,1-b]quinazoline-8-carboxylic acids.
    Schwender CF; Sunday BR; Herzig DJ; Kusner EK; Schumann PR; Gawlak DL
    J Med Chem; 1979 Jun; 22(6):748-50. PubMed ID: 88523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [1,4]Benzoxazine-2,3-diones as antiallergic agents.
    Loev B; Jones H; Brown RE; Huang FC; Khandwala A; Leibowitz MJ; Sonnino-Goldman P
    J Med Chem; 1985 Jan; 28(1):24-7. PubMed ID: 2578192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1,2,4-Triazolo[4,3-a]quinoxaline-1,4-diones as antiallergic agents.
    Loev B; Musser JH; Brown RE; Jones H; Kahen R; Huang FC; Khandwala A; Sonnino-Goldman P; Leibowitz MJ
    J Med Chem; 1985 Mar; 28(3):363-6. PubMed ID: 2579236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The activity of sodium cromoglycate analogues in human lung in vitro: a comparison with rat passive cutaneous anaphylaxis and clinical efficacy.
    Church MK; Gradidge CF
    Br J Pharmacol; 1980 Oct; 70(2):307-11. PubMed ID: 6159030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [2-(1H-Tetrazol-5-yl)-4,5-dihydroindeno[1,2-b]pyran-4-one].
    Görlitzer K; Dehne A; Engler E
    Arch Pharm (Weinheim); 1983; 316(3):264-70. PubMed ID: 6860092
    [No Abstract]   [Full Text] [Related]  

  • 30. REV 2871 (CHBZ): a potent antiallergic agent with a novel mechanism of action. I. Activity profile as an inhibitor of mediator release.
    Khandwala A; Coutts S; Pruss T; Jones H; Neiss E; Weinryb I
    Biochem Pharmacol; 1987 Mar; 36(5):663-72. PubMed ID: 2435293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-allergy actions of alkylphenyl alpha-D-mannopyranosides.
    Wang TC; Kakegawa H; Matsumoto H; Satoh T
    Biol Pharm Bull; 1994 Jan; 17(1):93-6. PubMed ID: 7511962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and antiallergic activities of 1,3-oxazolo[4,5-h]quinolines.
    Musser JH; Jones H; Sciortino S; Bailey K; Coutts SM; Khandwala A; Sonnino-Goldman P; Leibowitz M; Wolf P; Neiss ES
    J Med Chem; 1985 Sep; 28(9):1255-9. PubMed ID: 2411926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of immediate hypersensitivity reactions in laboratory animals by a phenanthroline salt (ICI 74,917).
    Evans DP; Thomson DS
    Br J Pharmacol; 1975 Mar; 53(3):409-18. PubMed ID: 48393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BL-5255, a tetrazolylpyrimidinone with potent oral antiallergy activity in animals.
    Siminoff P; Reed FC; Schurig JE; Juby PF
    Monogr Allergy; 1979; 14():318-23. PubMed ID: 91959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and structure-activity relationships of disodium cromoglycate and some related compounds.
    Cairns H; Fitzmaurice C; Hunter D; Johnson PB; King J; Lee TB; Lord GH; Minshull R; Cox JS
    J Med Chem; 1972 Jun; 15(6):583-9. PubMed ID: 4624147
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 2nd communication: inhibitory effects on histamine release from rat mast cells and lung fragments.
    Yanagihara Y; Abe T; Kuroda T; Shida T
    Arzneimittelforschung; 1988 Jan; 38(1):75-9. PubMed ID: 2452639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on antianaphylactic agents. 6. Synthesis of some metabolites of 6-ethyl-3-(1H-tetrazol-5-yl)chromone and their analogues.
    Nohara A; Kuriki H; Ishiguro T; Saijo T; Ukawa K; Maki Y; Sanno Y
    J Med Chem; 1979 Mar; 22(3):290-5. PubMed ID: 423211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiallergic properties of an orally effective agent, [[3-(1H-tetrazol-5-yl)-phenyl] amino] oxoacetic acid n-butyl ester.
    Agata M; Goto H; Tsuriya Y; Tachibana K; Kuroda T
    Jpn J Pharmacol; 1982 Aug; 32(4):689-97. PubMed ID: 6182323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413).
    Fukuda T; Saito T; Tajima S; Shimohara K; Ito K
    Arzneimittelforschung; 1984; 34(7):805-10. PubMed ID: 6208915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on antiallergic agents. I. Synthesis and antiallergic activity of novel pyrazine derivatives.
    Makino E; Iwasaki N; Yagi N; Ohashi T; Kato H; Ito Y; Azuma H
    Chem Pharm Bull (Tokyo); 1990 Jan; 38(1):201-7. PubMed ID: 1692517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.